Combining radium-223 with enzalutamide offered a survival benefit in metastatic castration-resistant prostate cancer, but experts questioned its relevance in a shifting treatment landscape.

Adding radium-223 to treatment with enzalutamide and a bone-protecting agent improved rPFS and OS in patients with mCRPC and ...

This report is a review of recent and emerging trends that promise to make radiation oncology for prostate cancer more ...

Men with castration-resistant prostate cancer (CRPC) and asymptomatic or mildly symptomatic bone metastases lived ...

The market for radioligand therapies (RLT), also known as radiopharmaceuticals, a relatively new kind of treatment, is ...

Discover they major updates in oncology from the 2024 ESMO Congress, including featured breakthroughs from the leading ...

Radioligand therapies (RLTs) have received prominent attention from major pharmaceutical companies in treating prostate ...

自进入临床以来，Ra-223积累了丰富的循证证据。整体而言，其临床应用是逐渐由后线治疗向早期治疗迈进，并在联合治疗策略中展现出令人振奋的疗效潜力。本次ESMO公布的RAPSON研究结果为早期启动Ra-223提供了新的证据，更重要的是为患者提供了更佳的 ...

A wide selection of therapies are available to treat advanced prostate cancer, but the optimal treatment strategy is unknown.

对于广大的mCRPC患者来说，这意味着什么呢？首先，医生在制定治疗方案时，应该积极考虑镭-223的早期治疗时机，合理安排治疗周期，以达到最佳生存获益。同时，患者也应积极与主治医生沟通，了解自己的治疗方案，增强自我管理的能力。

From Anil Kumble to Jasprit Bumrah, Indian bowlers have consistently outperformed many opposition bowlers at home over the ...